Procter & Gamble SEC Filings

The Procter & Gamble Company announced its Board declared a quarterly dividend of $1.0568 per share on its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after November 17, 2025, to shareholders of record on October 24, 2025.

The company also reported that, according to preliminary voting results, all fourteen Director nominees were elected at the Annual Meeting of Shareholders.

Insider sale to cover RSU taxes. The Form 4 shows Andre Schulten, Chief Financial Officer of Procter & Gamble (PG), sold 4,252 shares of common stock on 10/02/2025 at $152.2317 per share. The filing states the sale was to cover tax obligations upon settlement of a Restricted Stock Unit award. After the sale, the reporting person beneficially owned 53,992.0273 shares directly and 6,870.6545 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/06/2025.

Procter & Gamble (PG) director and CEO Jon R. Moeller reported a sale of 11,684 shares of Common Stock on 10/02/2025 at a reported price of $152.2317 per share to cover tax obligations from a Restricted Stock Unit award. After the sale, Mr. Moeller's direct beneficial ownership is reported as 319,932.232 shares. He also retains indirect holdings of 24,767.7039 shares through retirement plan trustees and 35,421.5707 shares attributed to his spouse, for combined reported beneficial ownership across direct and indirect holdings.

Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble (PG), reported a sale of 490 shares of common stock on 10/02/2025 at a price of $152.2317 per share to cover tax obligations related to a Restricted Stock Unit settlement. After the sale, the filing shows 12,616.0044 shares owned directly and an additional 5,166.0704 shares held indirectly via a retirement plan trustee, reflecting continued ownership after the transaction. The Form 4 was signed on 10/06/2025 by an attorney-in-fact for the reporting person.

Reporting person: Keith R. Alexandra, listed as an officer (CEO - Beauty). The filing discloses insider sales on 10/02/2025 of a total of 2,254 shares of Procter & Gamble Co (PG) to cover a tax obligation arising from settlement of a Restricted Stock Unit award. The reported sale price for each disposition was $152.2317. After the transactions the reporting person (directly and indirectly) held fractional share totals reported as 25,674.5056 (direct) and indirect interests via spouse and retirement plan trustee totaling additional fractional amounts. The form is signed by an attorney-in-fact on 10/06/2025.

Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported a sale of 3,986 shares of common stock on 10/02/2025 at a price of $152.2317 per share. The filing states the shares were sold to cover tax obligations arising from the settlement of a Restricted Stock Unit award. After the transaction the reporting person shows 46,899.3817 shares directly beneficially owned and additional indirect holdings of 3,331.1419 shares (by a retirement plan trustee), 19,757 shares (Sankhya S Jejurikar Revocable Trust) and 17,849 shares (Shailesh Jejurikar Trust).

The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing is single-person (not a group) and lists the transaction code as S denoting a sale; the explanatory footnote confirms the sale was to cover taxes on RSU settlement.

Jennifer L. Davis, an officer (CEO - Health Care) of Procter & Gamble Co (PG), reported a sale of 3,227 shares of common stock on 10/02/2025. The shares were sold at a reported price of $152.2317 and were sold to cover a tax obligation upon settlement of a Restricted Stock Unit award. After the transaction, the filing shows 61,763.9326 shares held directly and 15,535.3029 shares held indirectly through a retirement plan trustee, for combined beneficial ownership disclosed on the form.

The sale is described as a routine disposition to satisfy taxes tied to equity compensation rather than an open-market divestiture for liquidity. The form is signed by an attorney-in-fact and reports the transaction under Section 16 rules for insiders.

Insider sale to cover taxes following RSU settlement: An officer of Procter & Gamble (PG) reported a disposition of 3,535 shares of common stock on 10/02/2025 at a price of $152.2317 per share. After the sale, the reporting person holds 34,816.145 shares directly and additionally reports indirect holdings of 481.8949 shares (retirement plan trustee) and 1,295.35 shares (international plans).

The filing states the shares were sold to cover tax obligations upon settlement of a Restricted Stock Unit award, and the Form 4 was signed by an attorney-in-fact on 10/06/2025. This is a routine, compliance-driven transaction that reduced direct beneficial ownership by a measurable amount.

Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble Co (PG), reported an insider sale on 10/02/2025. The filing shows 2,408 shares of common stock were sold at a price of $152.2317 per share to cover taxes on a prior restricted stock unit grant.

After the transaction, Ms. Whaley beneficially owned 31,769.8354 shares directly and an additional 6,531.6011 shares indirectly through a retirement plan trustee. The Form 4 was signed by an attorney-in-fact on 10/06/2025, and the filing indicates compliance with Section 16 reporting requirements.